IDEXX Laboratories, Inc. 0J8P.L Stock
IDEXX Laboratories, Inc. Price Chart
IDEXX Laboratories, Inc. 0J8P.L Financial and Trading Overview
IDEXX Laboratories, Inc. stock price | 495.08 USD |
Previous Close | 471.19 USD |
Open | 0 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 510.36 USD |
Volume | 380 USD |
Avg. Volume | 1.74K USD |
Market Cap | 410.87M USD |
Beta (5Y Monthly) | 1.191901 |
PE Ratio (TTM) | 0.5584596 |
EPS (TTM) | 8.52 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0J8P.L Valuation Measures
Enterprise Value | 40.32B USD |
Trailing P/E | 0.5584596 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.11975198 |
Price/Book (mrq) | 46.9397 |
Enterprise Value/Revenue | 11.752 |
Enterprise Value/EBITDA | 38.601 |
Trading Information
IDEXX Laboratories, Inc. Stock Price History
Beta (5Y Monthly) | 1.191901 |
52-Week Change | 43.48% |
S&P500 52-Week Change | 20.43% |
52 Week High | 510.36 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 476.09 USD |
200-Day Moving Average | 431.66 USD |
0J8P.L Share Statistics
Avg. Volume (3 month) | 1.74K USD |
Avg. Daily Volume (10-Days) | 373 USD |
Shares Outstanding | 86.23M |
Float | 82.16M |
Short Ratio | N/A |
% Held by Insiders | 0.93% |
% Held by Institutions | 92.79% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 20.37% |
Operating Margin (ttm) | 27.12% |
Gross Margin | 59.70% |
EBITDA Margin | 30.44% |
Management Effectiveness
Return on Assets (ttm) | 21.54% |
Return on Equity (ttm) | 94.42% |
Income Statement
Revenue (ttm) | 3.43B USD |
Revenue Per Share (ttm) | 41.2 USD |
Quarterly Revenue Growth (yoy) | 7.59% |
Gross Profit (ttm) | 2B USD |
EBITDA | 1.04B USD |
Net Income Avi to Common (ttm) | 699.18M USD |
Diluted EPS (ttm) | 8.517 |
Quarterly Earnings Growth (yoy) | 10.40% |
Balance Sheet
Total Cash (mrq) | 111.37M USD |
Total Cash Per Share (mrq) | 1.34 USD |
Total Debt (mrq) | 1.32B USD |
Total Debt/Equity (mrq) | 156.96 USD |
Current Ratio (mrq) | 1.079 |
Book Value Per Share (mrq) | 10.133 |
Cash Flow Statement
Operating Cash Flow (ttm) | 612.19M USD |
Levered Free Cash Flow (ttm) | 398.99M USD |
Profile of IDEXX Laboratories, Inc.
Country | United Kingdom |
State | ME |
City | Westbrook |
Address | One IDEXX Drive |
ZIP | 04092 |
Phone | 207 556 0300 |
Website | https://www.idexx.com |
Industry | |
Sector(s) | |
Full Time Employees | 10780 |
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Q&A For IDEXX Laboratories, Inc. Stock
What is a current 0J8P.L stock price?
IDEXX Laboratories, Inc. 0J8P.L stock price today per share is 495.08 USD.
How to purchase IDEXX Laboratories, Inc. stock?
You can buy 0J8P.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IDEXX Laboratories, Inc.?
The stock symbol or ticker of IDEXX Laboratories, Inc. is 0J8P.L.
How many shares does IDEXX Laboratories, Inc. have in circulation?
The max supply of IDEXX Laboratories, Inc. shares is 863.82K.
What is IDEXX Laboratories, Inc. Price to Earnings Ratio (PE Ratio)?
IDEXX Laboratories, Inc. PE Ratio is 0.58128446 now.
What was IDEXX Laboratories, Inc. earnings per share over the trailing 12 months (TTM)?
IDEXX Laboratories, Inc. EPS is 8.52 USD over the trailing 12 months.